4 results
The objective of this study is to explore the efficacy and safety of gevokizumab in patients with Schnitzler syndrome.
The objective of this study is to evaluate the effect of the 4 successive monthly subcutaneous administrations of 30 mg of gevokizumab (in part A) , as well as 60mg (in part B) of the protocol, versus placebo on the reduction of arterial wall…
To examine the effects of mono- and combination therapy with linagliptin and empagliflozine on renal hemodynamics
7.1 Primary objectiveThe primary objective of the study is to assess the attitude towards the use of the MedRing 7.2 Secondary objectiveThe secondary objectives of the study are to assess device related adverse events, device damage and physician…